Financial reports
Current reports
8-K
Termination of a Material Definitive Agreement
29 Mar 22
8-K
Submission of Matters to a Vote of Security Holders
24 Mar 22
8-K
Other Events
14 Mar 22
8-K
Apria Announces Financial Results for Fourth Quarter and Full Year 2021
28 Feb 22
8-K
Highly Complementary Transaction Expands Patient Direct Offering
10 Jan 22
8-K
Apria Announces Financial Results for Third Quarter 2021
4 Nov 21
8-K
Departure of Directors or Certain Officers
7 Oct 21
8-K
Apria Announces Financial Results for Second Quarter 2021
5 Aug 21
8-K
Apria Announces Financial Results for First Quarter 2021
13 May 21
8-K
Departure of Directors or Certain Officers
6 May 21
Registration and prospectus
15-12B
Securities registration termination
8 Apr 22
25-NSE
Exchange delisting
29 Mar 22
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 22
424B4
Prospectus supplement with pricing info
12 Nov 21
S-1
IPO registration
8 Nov 21
DRS
Draft registration statement
3 Sep 21
424B4
Prospectus supplement with pricing info
10 Jun 21
S-1
IPO registration
7 Jun 21
DRS
Draft registration statement
30 Apr 21
S-8
Registration of securities for employees
12 Feb 21
Proxies
DEFA14A
Additional proxy soliciting materials
14 Mar 22
DEFA14A
Additional proxy soliciting materials
24 Feb 22
DEFM14A
Proxy related to merger
22 Feb 22
DEFA14A
Additional proxy soliciting materials
22 Feb 22
DEFA14A
Additional proxy soliciting materials
8 Feb 22
PREM14A
Preliminary proxy related to merger
7 Feb 22
DEFA14A
Additional proxy soliciting materials
21 Jan 22
DEFA14A
Additional proxy soliciting materials
13 Jan 22
DEFA14A
Additional proxy soliciting materials
10 Jan 22
DEFA14A
Additional proxy soliciting materials
10 Jan 22
Other
EFFECT
Notice of effectiveness
10 Nov 21
CORRESP
Correspondence with SEC
8 Nov 21
UPLOAD
Letter from SEC
13 Sep 21
EFFECT
Notice of effectiveness
10 Jun 21
CORRESP
Correspondence with SEC
7 Jun 21
UPLOAD
Letter from SEC
6 May 21
CERT
Certification of approval for exchange listing
11 Feb 21
EFFECT
Notice of effectiveness
11 Feb 21
CORRESP
Correspondence with SEC
9 Feb 21
CORRESP
Correspondence with SEC
9 Feb 21
Ownership
SC 13G/A
AMERICAN CENTURY INVESTMENT MANAGEMENT INC
8 Feb 23
SC 13G/A
VICTORY CAPITAL MANAGEMENT INC
6 Feb 23
SC 13G/A
ALGER ASSOCIATES INC
8 Apr 22
4
Mark E. Litkovitz
29 Mar 22
4
Robert P. Walker
29 Mar 22
4
STEPHEN A SCHWARZMAN
29 Mar 22
4
Christopher G Lee
29 Mar 22
4
Teresa L. Kline
29 Mar 22
4
Lynn Shapiro Snyder
29 Mar 22
4
CAPITAL PARTNERS V L P BLACKSTONE
29 Mar 22